1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings
Eratne, Dhamidhu ; Loi, Samantha M ; Li, Qiao-Xin ; Stehmann, Christiane ; Malpas, Charles B ; Santillo, Alexander LU
; Janelidze, Shorena
LU
; Cadwallader, Claire
; Walia, Nirbaanjot
and Ney, Blair
, et al.
(2022)
In Alzheimer's & Dementia
- Contribution to journal › Article
- 2019
-
Mark
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
Shaw, Leslie M. ; Hansson, Oskar LU
; Manuilova, Ekaterina
; Masters, Colin L.
; Doecke, James D.
; Li, Qiao Xin
; Rutz, Sandra
; Widmann, Monika
; Leinenbach, Andreas
and Blennow, Kaj
LU
(2019)
In Clinical Biochemistry
72.
p.7-14
- Contribution to journal › Article
-
Mark
Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays : Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid
- Contribution to journal › Article